Roshan Agarwal

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. ncbi Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia
    R Agarwal
    Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College Healthcare NHS Trust, Fulham Palace Road, London W6 8RF, UK
    Br J Cancer 106:1089-94. 2012
  2. ncbi PI3K pathway-directed therapeutic strategies in cancer
    Roshan Agarwal
    Imperial College London, Department of Oncology, Hammersmith Hospital, Du Cane Road, W12 0NN, UK
    Curr Opin Investig Drugs 11:615-28. 2010
  3. ncbi Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study
    Peter Schmid
    Imperial College London, UK
    Lancet 374:48-55. 2009
  4. ncbi HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer
    Euan A Stronach
    Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, Edinburgh, United Kingdom
    Cancer Res 71:4412-22. 2011

Collaborators

Detail Information

Publications4

  1. ncbi Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia
    R Agarwal
    Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital, Imperial College Healthcare NHS Trust, Fulham Palace Road, London W6 8RF, UK
    Br J Cancer 106:1089-94. 2012
    ....
  2. ncbi PI3K pathway-directed therapeutic strategies in cancer
    Roshan Agarwal
    Imperial College London, Department of Oncology, Hammersmith Hospital, Du Cane Road, W12 0NN, UK
    Curr Opin Investig Drugs 11:615-28. 2010
    ....
  3. ncbi Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study
    Peter Schmid
    Imperial College London, UK
    Lancet 374:48-55. 2009
    ..We aimed to assess the long-term outcome of stage-adapted management by surgery, chemotherapy, or both for patients with the disorder...
  4. ncbi HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer
    Euan A Stronach
    Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, Edinburgh, United Kingdom
    Cancer Res 71:4412-22. 2011
    ..Together, our findings identify HDAC4 as a novel, therapeutically tractable target to counter platinum resistance in ovarian cancer...